EUVIMEDEUVIMED entdecken
Open Access

Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson’s Disease

Yasuhiro Fujiwara, Nobutaka Sakae, Hiroyuki Kumazoe, Kouta Miyamoto, Yoshinori Hirakawa, Hirohito Kan, Kosuke Yamashita, Mika Kitajima

Magnetic Resonance in Medical Sciences · 2026

DOI: 10.2463/mrms.mp.2025-0045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance in Medical Sciences, 2026. Verfasst von Yasuhiro Fujiwara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging Technology, Faculty of Life Sciences, Kumamoto University, Kumamoto Kumamoto, Japan. Hauptthemen laut MEDLINE: Parkinson Disease, Magnetic Resonance Imaging, Brain, Brain Mapping. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aimed to evaluate the diagnostic potential of macromolecular proton fraction (MPF) mapping combined with magnetic susceptibility measurements as subcortical biomarkers in Parkinson's disease (PD). METHODS: Twenty patients with PD and 9 age-matched healthy controls underwent 3.0T magnetic resonance imaging, including MPF mapping and quantitative susceptibility mapping (QSM). MPF and magnetic susceptibility values of the 16 subcortical nuclei were measured in both the PD group and healthy control group, and these values were compared between the 2 groups. Diagnostic performance of MPF and magnetic susceptibility in the subcortical nuclei was individually evaluated using receiver operating characteristic (ROC) analysis. A logistic regression model was developed for the diagnosis of PD using a combination of MPF and magnetic susceptibility values. RESULTS: Quantitative analyses revealed significantly reduced MPF values (false discovery rate-corrected P < 0.05) in 7 subcortical nuclei in the PD group, namely the hypothalamus, parabrachial pigmented nucleus, red nucleus, substantia nigra pars reticulata, substantia nigra pars compacta, ventral pallidum, and ventral tegmental area. Additionally, magnetic susceptibility was significantly elevated (false discovery rate-corrected P < 0.05) in the parabrachial pigmented nucleus and substantia nigra pars compacta. ROC curve analysis demonstrated strong diagnostic performance, with the ventral pallidum showing the highest MPF-based diagnostic accuracy (area under the curve [AUC] = 0.82) and the substantia nigra pars compacta showing the highest QSM-based accuracy (AUC = 0.88). The logistic regression model combining MPF and magnetic susceptibility showed the best performance (AUC = 0.93). CONCLUSION: MPF mapping, particularly when combined with magnetic susceptibility measurements, may serve as a quantitative diagnostic biomarker for PD, and the observed widespread alterations across multiple subcortical nuclei provide new insights into the pathology of PD beyond the classic nigrostriatal pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMagnetic Resonance ImagingBrainBrain MappingHumansMaleFemaleBiomarkersMiddle AgedAgedProtonsCase-Control StudiesROC Curve

Stichwörter der Autor:innen

Parkinson’s diseasemacromolecular proton fraction mappingsubcortical biomarkers

Substanzen

BiomarkersProtons

Autor:innen und Institutionen

  • Department of Medical Imaging Technology, Faculty of Life Sciences, Kumamoto University, Kumamoto Kumamoto, Japan.
  • Department of Neurology, National Hospital Organization Omuta National Hospital, Omuta Fukuoka, Japan.
  • Department of Radiology, National Hospital Organization Omuta National Hospital, Omuta Fukuoka, Japan.
  • Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya Aichi, Japan.
  • Department of Diagnostic Imaging Technology, Faculty of Life Sciences, Kumamoto University, Kumamoto Kumamoto, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujiwara, Y., Sakae, N., Kumazoe, H., Miyamoto, K., Hirakawa, Y., Kan, H., Yamashita, K., & Kitajima, M. (2026). Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson’s Disease. Magnetic Resonance in Medical Sciences. https://doi.org/10.2463/mrms.mp.2025-0045

Vancouver

Fujiwara Y, Sakae N, Kumazoe H, Miyamoto K, Hirakawa Y, Kan H, et al. Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson’s Disease. Magnetic Resonance in Medical Sciences. 2026. doi:10.2463/mrms.mp.2025-0045

BibTeX
@article{Fujiwara2026,
  author = {Fujiwara, Yasuhiro and Sakae, Nobutaka and Kumazoe, Hiroyuki and Miyamoto, Kouta and Hirakawa, Yoshinori and Kan, Hirohito and Yamashita, Kosuke and Kitajima, Mika},
  title = {Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson’s Disease},
  journal = {Magnetic Resonance in Medical Sciences},
  year = {2026},
  doi = {10.2463/mrms.mp.2025-0045}
}
Kostenlos starten →